• MPAL.L is trading 5.4% down at $3.98 today, pulling back after a significant rally.
  • The decline follows a surge in shares on July 1, 2026, likely driven by the start of Medicare coverage for GLP-1 weight-loss medications, a major positive catalyst for the sector.
  • While no new company-specific catalysts were announced today, the GLP-1 sector saw heightened activity with Medicare's expanded coverage, a development that MedPal AI, with its New Health GLP-1 weight management platform, is positioned to address.